Is NCT02571569 results overdue?

Yes — results are overdue. Primary completion was 2018-07-09; the FDAAA-801 reporting deadline (2019-07-09) passed 2585 days ago and no results are posted on ClinicalTrials.gov.

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

NCT ID	NCT02571569 ↗
Sponsor	Bayer (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-07-09 (ACTUAL)
Reporting deadline	2019-07-09 (completion + 365d)
Days overdue	2585
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-07-14 · SHA-256 `6224f0487dd99718…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02571569. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.